GenSight Biologics announced that an oral presentation will be presented at the American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting taking place virtually on May 12-15, 2020.

The ASGCT abstracts are now available at

Details for the oral presentation are as follows.


GS030 – Optogenetics in Retinitis Pigmentosa (RP)


Title:  Optogenetics in the Clinic: PIONEER, a Phase 1/2a Gene Therapy Program for Non-Syndromic Retinitis Pigmentosa (abstract #506)

Presenter:  Joseph Martel, MD, Assistant Professor of Ophthalmology Retina and Vitreous Servious, UPMC Eye Center – Eye & Ear Institute, Pittsburg, PA (US)

Session Date/Time: Wednesday May 13, 2020 4:30pm – 4:45pm ET

Session title: AAV Vectors – Clinical Studies II